Life science strategy needs wider focus
By Dr Graeme Macaloney
Canada has made world leading progress in life science R&D, but faces critical issues with respect to commercialization. With over 540 products, our biopharma pipeline is one of the fullest internationally.
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 0 free articles remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.